Mirum Pharmaceuticals to release Phase 3 hepatitis delta trial data

September 27, 2026 5:00 PM

Mirum Pharmaceuticals (NASDAQ: MIRM) announced it will host an investor call on September 28, 2026, to share ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found